Name: UMIN ID:
Unique ID issued by UMIN | UMIN000046619 |
---|---|
Receipt number | R000045060 |
Scientific Title | All-Patient General Drug Use Surveillance of Rozlytrek Capsule -ROS1 fusion gene-positive unresectable advanced or recurrent non-small cell lung cancer- |
Date of disclosure of the study information | 2022/01/13 |
Last modified on | 2024/07/17 13:54:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2022/01/13 07:50:07 | ||
2 | Update | 2022/08/01 10:41:48 | Recruitment status Date of IRB |
|
3 | Update | 2022/12/28 06:49:35 | Email |
|
4 | Update | 2023/05/30 17:09:02 | Email |
|
5 | Update | 2024/07/17 13:53:52 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
6 | Update | 2024/07/17 13:54:58 | Recruitment status |